(Q40511929)

21 September 2017

title

Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapy (English)

1 reference

21 September 2017

Bissett D

1

1 reference

21 September 2017

Paul J

2

1 reference

21 September 2017

Wishart G

3

1 reference

21 September 2017

Jodrell D

4

1 reference

21 September 2017

Machan MA

5

1 reference

21 September 2017

Harnett A

6

1 reference

21 September 2017

Canney P

7

1 reference

21 September 2017

George WD

8

1 reference

21 September 2017

Kaye S

9

1 reference

21 September 2017

publication date

1 January 1995

1 reference

21 September 2017

1 reference

21 September 2017

volume

7

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

12-15

1 reference

Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980629-6

7 January 2021

Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980629-6

7 January 2021

Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980629-6

7 January 2021

The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980629-6

7 January 2021

Chemotherapy of disseminated breast cancer:Current status and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980629-6

7 January 2021

A meta-analysis of reported correlations between prognostic factors in breast cancer: Does axillary lymph node metastasis represent biology or chronology?

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980629-6

7 January 2021

Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980629-6

7 January 2021

A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980629-6

7 January 2021

Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980629-6

7 January 2021

10.1016/S0936-6555(05)80629-6

Identifiers

DOI

1 reference

21 September 2017

1 reference